title: Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes.
abstract: Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12-21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes.
authors: Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Ct,, Mail Stop F527, Aurora, CO, 80045, USA. Franziska.Bishop@ucdenver.edu.
authors: Franziska K
authors: FK
authors: Bishop
authors: R Paul
authors: RP
authors: Wadwa
authors: Sam
authors: S
authors: Ellis
authors: Marian
authors: M
authors: Rewers
authors: David M
authors: DM
authors: Maahs